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ABSTRACT 
 
 Little information is known on what demographic, behavioral, and procedural 
factors influence the number of polyps found during a colonoscopy screening for 
colorectal cancer (CRC). The main objective of this study is to describe the polyp 
detection rate (PDR), number of polyps removed, and predictors of polyp count overall 
and for high-risk polyps among uninsured patients undergoing colonoscopy in the 
Colorectal Cancer Prevention Network (CCPN) program of South Carolina. We 
performed a secondary data analysis on CCPN data for colonoscopies performed between 
May 2014 and May 2017. We assessed the association of polyp count with the following 
variables: age, race, gender, smoking status, alcohol use, BMI, family history of CRC, 
education status, NSAID use, physical activity, rural/urban residence, bowel preparation 
quality, and time of procedure. We hypothesized that since these variables have been 
shown to influence the risk of colonic polyps they will also influence the number of all 
polyps and number of high-risk polyps detected during colonoscopy. Total PDR within 
this study was 61.82%. Respective mean, median, and max number of polyps removed 
were 1.65, 1.00, and 15 for all polyps and 0.31, 0, and 13 for high-risk polyps. 
Multivariable analyses found male gender, current and former smokers, moderate alcohol 
use, family history of CRC, obesity, and never using NSAIDS to be positively associated 
with total number of polyps detected; rural residence was negatively associated with 
number of total polyps. Males, current smokers, and using NSAIDS 1-3 days/week, 
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occasionally, or never were found to have a higher number of high-risk polyps. A later 
procedure time resulted in a lower number of high-risk polyps than the earliest procedure 
times. This study demonstrates the effects that demographic, behavioral, and procedural 
influencers have on polyp detection and the number of polyps detected during a 
colonoscopy procedure. Based on these relationships, our findings may help to identify 
individuals who are at risk for a high number of polyps, which could possibly lead to 
better detection of polyps during their colonoscopy procedure. 
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CHAPTER 1 
INTRODUCTION
Colorectal cancer (CRC) is the third most common type of cancer for men and 
women in the United States and in South Carolina.1,2 The American Cancer Society 
(ACS) estimates that about 140,250 cases of colon and rectal cancer will be diagnosed in 
2018.2 Colonoscopies are an effective primary prevention method of CRC because they 
remove cancer-causing polyps and detect early signs of cancer.3 These procedures have 
reduced CRC incidence and risk of death.4–7 
Although colonoscopies are effective at reducing the risk for CRC, they can be 
expensive procedures. The cost for a colonoscopy screening averages between $586 to 
$2,146 depending on health insurance type and the facility in which the screening is 
performed.8,9 Because of these high costs, colonoscopy screening rates for U.S. adults 
who are uninsured is lower than the rate for those who do have health insurance.2,3,10–12 
This makes the uninsured population more susceptible to colorectal polyps and CRC, and 
more likely to be diagnosed at an advanced stage than those who have health 
insurance.2,13 About 10.0% of South Carolina residents did not have health insurance in 
2016,14 and only 71.3% of the state’s adult residents aged 50+ have ever received a 
colorectal endoscopy (as of 2014)15 which makes the uninsured individuals in this state of 
particular concern for colorectal polyps and CRC.  
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The U.S. Preventive Services Task Force (USPSTF) recommends CRC screening 
for those between the ages of 50 and 75, or sooner than 50 years if an individual is among 
a high-risk group for developing CRC- such as African-Americans.1 However, the ACS 
now recommends screening for average-risk individuals aged 45-50.16 Many different 
factors may contribute to an individual’s risk status. These include race, age, gender, 
BMI, smoking, physical activity, family history of CRC, alcohol use, nonsteroidal anti-
inflammatory drug (NSAID) use, rural vs. urban residence, and education, all which have 
all been found to be associated with the risk of adenoma polyps.1,2,17–25  
Non-Hispanic blacks are more at risk to develop CRC when compared to non-
Hispanic whites, and are also less likely to receive a colonoscopy screening.1,10,18 From 
2010 through 2014, non-Hispanic blacks had a 40% higher CRC death rate than non-
Hispanic whites. Regardless of race, males have a higher incidence rate and mortality rate 
than women.2,17,18 Additionally, the probability of developing CRC increases with age 
and is the highest among those who are 70 years or older.2 Some types of NSAIDs, 
regular physical activity, and higher education levels have been shown to decrease the 
risk of colonic adenomas.1,22,26 Smoking, having a high BMI, and frequently drinking 
alcohol are all well known risk factors for developing colorectal polyps.18,26,27 Having a 
first-degree relative with a history of CRC can increase one’s risk for developing CRC.23 
Additionally, colonoscopy screening rates are lower in rural areas than they are in urban 
areas.21 Rural residents often have long travel distances to a screening provider which has 
been shown to have higher odds of being diagnosed with a late-stage CRC as compared 
to those who live closer to a provider.20  
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In an effort to improve upon the colorectal screening rates in South Carolina’s 
uninsured population, the Center for Colon Cancer Research (CCCR) at the University of 
South Carolina established the Colorectal Cancer Prevention Network (CCPN) in 2008 
which provides free colonoscopy screenings to those who are uninsured and meet the 
program’s eligibility requirements. Between May 2014 and May 2016, the CCPN 
program completed 909 colonoscopies and found that 6.6% were normal, 41.6% were 
hyperplastic polyps, 28.0% were non-advanced adenomas, 22% were advanced 
adenomas, and about 1% of patients were diagnosed with CRC or carcinoid tumor.28 The 
overall polyp detection rate (PDR) of the procedures was 63%, and the adenoma 
detection rate (ADR) was 36%.28 
Studies have found that polyp count, or the number of polyps discovered in the 
colon during colonoscopy, has an influence on cancer risk. When polyp density increases, 
the risk of CRC also increases.29 Although many studies have focused on what 
demographic and behavioral factors make people more at risk for high-risk polyps and 
colorectal cancer, there seems to be a knowledge gap on what specific factors may 
influence the quantity of polyps detected during a colonoscopy procedure.  
The main objective of this study is to describe the polyp detection rate, number of 
polyps removed (overall and by risk type), and predictors of polyp count among 
uninsured patients undergoing colonoscopy in the CCPN program of South Carolina. We 
will be focusing on those patients who received colonoscopy procedures between May 
2014 and May 2017. Our aims include (1) calculating the PDR overall and for each 
independent variable, (2) describing the mean, median, and max of polyps removed, and 
(3) determining the association of demographic and lifestyle characteristics on number of 
4	
polyps detected (overall and high-risk only) during colonoscopy for patients participating 
in the CCPN screening program. 
Since our study sample consists of uninsured and low-income patients, we expect 
to see a relatively large PDR. Persons who are of older age, African-American, male, 
currently smoke, live in a rural area, participate in zero days of vigorous physical activity 
per week, have fair-to-poor quality of bowel preparation, family history of CRC, heavily 
drink alcohol, never use NSAIDs, have less than high school education, and who are 
obese/overweight are expected to have a significantly higher PDR than their counterparts. 
We also expect these individuals to have a larger number of polyps removed during 
colonoscopy. We hypothesize that these factors that have been shown to increase the risk 
of colonic polyps will also increase the risk of overall number of polyps detected during 
colonoscopy.   
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CHAPTER 2	
LITERATURE REVIEW
2.1 COLORECTAL CANCER BURDEN IN THE U.S. AND SOUTH CAROLINA 
According to the American Cancer Society (ACS), about 1.7 million new cases of 
cancer are expected to be diagnosed in 2018, with 140,250 of those being colon and 
rectal cancers.2 The ACS estimated new cases of colorectal cancer (CRC) in 2018 to be 
higher among males (n= 75,610) than females (n= 64,640).2 The death rates of CRC also 
tend to vary by sex. The 2011-2015 CRC death rate for males in the United States was 
about 17.3 per 100,000, whereas this rate was 12.2 per 100,000 for females.2 These rates 
are slightly higher in the state of South Carolina, where the 2011-2015 CRC death rates 
for males and females were 18.0 and 12.6, respectively.2 The ACS estimates that in 2018 
the total number of deaths from CRC will be approximately 50,630 in the U.S. and 860 in 
South Carolina.2 
Not only does sex influence CRC risk, but other factors such as age and race can 
have an effect. The probability of developing CRC increases with age, and is highest 
amongst those aged 70+.1,2 African Americans have a higher CRC mortality rate and a 
lower screening rate than whites.1,2,25,30 Moreover, the risk of CRC is affected by whether 
or not someone has had a CRC screening. Screening rates are higher among women, 
whites, and increase with age.8 Only about 71.3% of South Carolina’s eligible population 
had ever received a colorectal endoscopy in 2014, which is slightly higher than the U.S. 
value of 69.1%.15 Due to the potentially high costs of CRC screening, screening rates are 
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affected by health insurance status. Those without health insurance are less likely to 
receive a CRC screening and more likely to be diagnosed with CRC than those with 
health insurance.9,11 Therefore, the groups most at risk for developing CRC are males, 
African-Americans, those of older age, and those without health insurance.  
 
2.2 TYPES OF HIGH-RISK POLYPS  
The removal of an adenomatous colonic polyp reduces the risk of death from 
CRC by about 53%.7 During a colonoscopy, the performing physician removes the high-
risk polyps which have the potential to develop into cancer.7 High-risk polyps are those 
that are neoplastic and have the potential to become malignant.31,32 Polyps with high 
grades of dysplasia, increased percentage of villous tissues, and ³1cm in diameter are 
associated with an increased risk of malignancy and considered advanced adenomas.31–33 
There are multiple types of polyps which are all classified as either neoplastic 
(cancerous) or non-neoplastic (non-cancerous).31–33 Non-neoplastic polyps are those with 
no malignant potential, such as hyperplastic polyps, hamartomas, lymphoid aggregates, 
and inflammatory polyps.31,32 The more high-risk/malignant polyps are neoplastic polyps 
which are classified as tubular adenomas (0-25% villous tissue), tubulovillous adenomas 
(25-75% villous tissue), and villous adenoma (75-100% villous tissue).31,32 Over 95% of 
colorectal cancers result from these types of neoplastic adenoma polyps.32 Recent studies 
have also found that sessile serrated adenomas/polyps and traditional serrated adenomas 
that had previously been classified as low-risk hyperplastic polyps have potential to 
develop into cancer and should be treated as high-risk.34 Small hyperplastic polyps (<1 
cm in diameter) are generally considered low-risk as they rarely develop into cancer.33,34 
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2.3 RISK FACTORS FOR HIGH-RISK POLYPS AND CRC 
Smoking 
 Smoking is a risk factor for colonic polyps, adenomas, and CRC.2,19,24,26,35,36 
Cigarettes release carcinogens into the blood stream which can cause malignancies in 
organs throughout the body.18 In a study by Shrubsole et al., they found a strong dose-
response association for years of smoking and risk of colonic polyps. The odds ratio (OR) 
of smoking for 35+ years compared to those who never smoked was 5.0 (95% CI 3.3-7.3) 
for hyperplastic polyps, 1.9 (95% CI 1.4-2.5) for adenoma polyps, and 6.9 (95% CI 4.4-
11.1) for both adenomas and hyperplastic polyps.35 
 Another study by Fu et al., found that when compared to those who never smoke, 
those who currently smoke ³30 pack-years had the strongest association for adenomatous 
polyp risk with an OR=2.05 (95% CI 1.62-2.61), while also finding significant 
associations for those who currently smoke <30 pack-years and former smokers.26 
Similar to Shrubsole et al.,35 cigarette smoking was found to be more strongly associated 
with hyperplastic polyps than adenomatous polyps.26 Overall, this study found the 
strongest association was between developing both adenomatous polyps and hyperplastic 
polyps for those who currently smoke ³30 pack-years with an OR=7.01 (95% CI 5.02-
9.79).26 
 
BMI 
 Individuals who have a body-mass index (BMI) of ³25 kg/m2 (“overweight” or 
“obese”) have higher odds than those with a BMI <25 kg/m2 of developing adenomas and 
advanced adenomas.2,18,19,24,26,36,37 When compared to those of normal weight, Shapero et 
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al., found significant ORs for adenoma among those who are overweight (OR=1.80, 95% 
CI 1.06-1.83) and those who are obese (OR=1.72, 95% CI 0.99-2.99), as well as 
advanced adenoma for those who are obese (OR=1.8, 95% CI 1.09-2.96).19 
 Furthermore, the association between BMI and colorectal polyps has been shown 
to be stronger among men than women.37 In a study by Sato et al., the OR for colorectal 
polyps in obese men compared to non-obese men was 1.34 (95% CI 1.17-1.54) and 
increased as BMI increased.37 The OR found for obese women was 1.13 (95% CI 0.92-
1.39) and also increased with BMI, but was insignificant.37 
 
Physical Activity 
 Many studies have found that those who engage in physical activity are less likely 
to develop colonic polyps.2,22,36,38 One study found that physical activity is more strongly 
associated with reducing the risk of advanced adenomas than the risk of non-advanced 
adenomas.38 In a study by Sanchez et al.,22 those who exercised at least one hour per 
week had a significantly lower polyp prevalence compared to those do did not regularly 
exercise for both adenomas (13.8% vs 18.9%) and any polyps (25.2% vs 33.2%). They 
also assessed the relationship when active individuals were classified as those who 
exercised at least 3 hours a week and found that they still had a lower prevalence of 
adenomas and advanced adenomas.22 When long-term exercisers were compared to those 
who only recently began regular exercise, those who had a history of exercising 5+ years 
tended to have fewer adenomas than their counterpart.22  
 The protective aspects of physical activity on polyp risk have also been shown to 
vary based on multiple demographic factors. The Sanchez et al., study found that 
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African-Americans and Hispanics benefit most from physical activity’s effect on polyp 
risk, and whites and Asians were not found to have any large beneifts.22 Some studies 
have found a stronger association between physical activity and reduced risk of adenoma 
among men than women.38 However, a systematic literature review and meta-analysis 
found that these physical activity benefits are similar among male and females, with 
respective relative risks of adenoma at 0.81 and 0.87.39 Lastly, among those who are 
overweight or obese, individuals who engaged in physical activity were significantly less 
likely to have adenomas and advanced adenomas (13.5%) than those who did not 
exercise (20.5%).22 
 
Alcohol Consumption 
 The effect of alcohol consumption on the risk of adenoma polyps has varied 
across studies.2,27,35,36 Some studies have found that those who drink alcohol are more 
likely to have adenomas or hyperplastic polyps,27,36 while others have found no 
significant association between the two factors.35 One study found that those who had 
consumed alcohol for 30+ years had a weak and non-significant increased risk for 
hyperplastic polyps, and found no dose-response relationship.35 Overall, results showed 
alcohol was not associated with the risk of adenoma, hyperplastic polyp, or both.35 Other 
study results oppose these findings. According to Song et al., the odds of advanced 
adenoma among those who drink alcohol are 2.70 (95% CI 1.44-5.06) times the odds of 
advanced adenoma among those who do not drink alcohol.27  
 Although there is some disagreement in the association between alcohol and risk 
of polyps, a systematic review and meta-analysis by Zhu et al. found that most studies 
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have confirmed alcohol to be a significant risk factor for polyps.40 In general, alcohol 
drinkers were found to have a 17% increased risk for adenoma compared to those who do 
not drink, and the summarized relative risk for adenoma and alcohol consumption in the 
U.S. was found to be 1.12 (95% CI 1.05-1.20).40 
 
Race 
 African-Americans are more likely to develop colorectal polyps and CRC than 
any other racial group.1,2,18,22 A study by Sanchez et al., found African-Americans to have 
the greatest incidence of all polyps, adenoma, and advanced adenoma, and also have the 
highest detection rate for any polyp (30.8%), adenoma (20.8%), and advanced adenoma 
(6.7%).22 Whites were found to be significantly less likely to have polyps detected 
compared any other race.22  
 According to Grahn et al., multiple studies have found that the odds of CRC are 
greatest for African-Americans and lowest for Hispanics and Asian-Americans when 
compared to Whites. Studies have also found African-Americans to have the highest 
incidence rates of CRC and cancer related mortality, and an increased risk for large 
polyps.18 Lastly, some have found that there are significantly more African-Americans 
with CRC under the age of 50 than any other race.1,18 
 
Age  
 The likelihood of a colonic adenoma has been shown to increase as age 
increases.1,2,19,24,35 According to the American Cancer Society,2 age increases the 
probability of developing CRC for both males and females. The age group 70+ has the 
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highest probability of CRC for both males (3.4%, or 1 in 29) and females (3.1%, or 1 in 
32).2 Those of older age have also been found to have a stronger association with 
advanced adenomas than with non-advanced adenomas.24 
 
Gender 
 Males are more likely to develop a colonic adenoma than females.18,19,26,35,36 
Some studies have additionally found that men develop colonic lesions at an earlier age 
than women do.18 A study by Burnett-Hartman et al., found that women had a 40% (95% 
CI 21-55%) decrease in odds of adenoma compared to men, but that the odds of a 
serrated polyp was not associated with gender (OR 1.06, 95% CI 0.99, 2.44).24  
 
Education 
 Individuals with a lower education status have an increased risk of CRC 
compared to those who have a higher education status.26,35,36,41 Those with a lower 
education level are also more likely to have adenoma polyps, hyperplastic polyps, and a 
combination of these two types.26,35 Doubeni et al. found that the incidence of CRC 
increases with decreasing levels of educational level. Those with less than 12 years of 
education had a 42% higher risk of incidence of CRC (IRR 1.42, 95% CI 1.29-1.56) 
when compared to those with a postgraduate education.41 
 
NSAID Use  
 Although regular NSAID use may be a risk factor for some adverse health events 
such as stomach bleeding, they are a protective factor for colonic polyps.2,26,36,42 A study 
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by Murff et al. found a reduced risk of adenomas in regular users of aspirin or non-aspirin 
NSAIDs. Using non-NSAID users as the referent group, the OR for those who used baby 
aspirin was 0.79 (95% CI 0.66-0.93) and was 0.60 (95% CI 0.47-0.76) for those who 
used a combination of NSAIDs.36 Additionally, there was a dose-response relationship 
for all aspirin and non-aspirin NSAID categories and risk of adenomas.36 
 Johnson et al. also performed a similar study and found regular use of aspirin only 
NSAIDs protective for hyperplastic polyps, adenomas, and advanced adenomas, while 
regular use of ibuprofen only NSAIDs was protective only for advanced adenomas.42 A 
combined use of both aspirin and ibuprofen NSAIDs was associated with a lower 
prevalence of all three of these types of polyps. When assessed with age and BMI, the 
investigators found NSAID use provided stronger protection against polyps for those who 
were 70-74 years old compared to those who were 55-69 years old, and also slightly more 
protection for those with a BMI <25 compared to those ³25 (overweight/obese).42 
 
Family History of CRC 
 Family history of CRC has also been associated with high-risk polyps and 
colorectal cancer.2,23,38 One study by Kerber et al. defined family history as one or more 
first degree relative(s) that had ever had cancer of the colon, rectum, or large bowel, and 
found that those with this description were positively associated with colon cancer risk 
(OR=1.77, 95% CI 1.47-2.13).23 They discovered the increased risk of colon cancer for 
those with a family history of CRC was higher among males (RR=1.95, 95% CI 1.51-
2.53) than females (RR=1.60, 95%CI 1.22-2.11), and was more strongly associated with 
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those <67 years old (OR=1.91, 95% CI 1.43-2.54) than those ³67 years old (OR=1.65, 
95% CI 1.29-2.11).23  
 
Rural/Urban Residence 
 Residence location (urban or rural area) has been found to have an effect on CRC 
risk. A study by Kinney et al. found that rural residence is associated with an increased 
risk of colon cancer with an OR of 1.40 (95% CI 1.1-1.8).43 Additionally, they found that 
those who resided in rural areas had an increased risk of local (OR 1.40 95% CI 1.0-2.1) 
and regional/advanced disease (OR 1.40 95% CI 1.0-1.9) at time of diagnosis than their 
urban-dwelling counterparts.43 
 
Additional Factors 
 Not only are demographic and behavioral factors influential on the detection of 
polyps, but the colonoscopy results can be influenced by other outside factors as well. 
Colonoscopy procedure quality based on the performing physician’s adenoma detection 
rates (ADR) can impact whether or not a high-risk polyp is detected as physician’s with a 
higher ADR may have more enhanced detection of polyps.44 ADR has been found to be 
inversely associated with the risk of subsequent CRC following colonoscopy.44 
Additionally, bowel preparation during colonoscopy can have an effect on polyp 
detection. According to Hong, et al., the rate of missed polyps and adenomas per-patient 
significantly increased as the quality of bowel preparation decreased.45 Because of these 
findings, it is important to consider physician level variance and bowel preparation when 
assessing colonoscopy results.  
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2.4 PREDICTORS OF POLYP COUNT 
 The number of colonic polyps detected during colonoscopy has been associated 
with the risk of CRC. A study by Debenski et al. found that cancer risk increases with the 
amount of polyps detected. Among patients of the same ages who received a colectomy 
(a surgical resection of all or part of the colon) due to familial adenomatous polyposis, 
those with ³1000 polyps had 2.3 (95% CI 1.3-4.1) times the cancer risk of those with 
<1000 polyps.29 Therefore, the number of polyps detected during colonoscopy procedures 
is important in assessing CRC risk.  
 Few studies have assessed any associations with number of polyps detected 
during colonoscopy. Some have measured the association between number of polyps 
found and system based factors- such as time of day the colonoscopy is performed. A 
study by Chan et al. found that the time of day colonoscopy is performed is associated 
with the number of polyps discovered. Their results showed that physicians may be more 
likely to detect polyps at the beginning of the day rather than later in the day.46 Bowel 
preparation status has also been shown to increase the risk of missing polyps and 
adenomas during colonoscopy.45,47 The results from a study by Papanikolaou et al., found 
that bowel preparation quality effects the number of polyps detected during 
colonoscopy.47 They assessed two preparation methods: full dose (4-L of polyethylene 
glycol “PEG” given on previous day of procedure) and split-dose (3-L of PEG given on 
previous day, 1-L on same day of procedure). They found that the split-dose method 
provided increased bowel cleanliness and the number of polyps that were detected.47 
Table 2.1 demonstrates the evidence found from these two mentioned studies. 
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To our knowledge, no studies have assessed the relationship between other 
individual factors (such as those listed in section 2.3) and the quantity of polyps detected 
during colonoscopy. Therefore, our study aims to fill this knowledge gap. Our main 
purpose is to assess the association between the individual factors: smoking, BMI, 
physical activity, alcohol, race, age, gender, education, NSAID use, family history of 
CRC and rural/urban location and the number of polyps detected during colonoscopy 
Additionally, we will assess the effect of time of day procedure occurred and bowel 
preparation as predictors of polyp count based on the findings of the aforementioned 
studies.  
 
Table 2.1: Evidence Table for Predictors of Polyp Count 
 
Main Author Year(s) Setting Main Outcome Results 
Chan, Michael 2006- 
2007 
West Los Angeles 
Veteran’s 
Administration 
Medical Center; 
(Los Angeles, 
CA) 
Polyp yield More polyps were detected 
in colonoscopies that 
received colonoscopies 
earlier in the day compared 
to later procedures; 
Reduction in adenoma 
detection as day progresses 
Papanikolaou, 
Ioannis 
2012 Attikon 
University 
General Hospital; 
(Athens, Greece) 
Difference between 
number of polyps 
detected during 
colonoscopies prepared 
by split-dose bowel 
preparation and 
previous dose 
preparation 
Split-dose bowel 
preparation significantly 
associated with an 
increased number of 
polyps detected; split-dose 
preparation improves colon 
cleansing and enhances 
polyp detection 
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CHAPTER 3 
METHODS 
3.1 STUDY POPULATION AND DATA SOURCE 
 We performed a secondary analysis on data obtained from the Center for Colon 
Cancer Research’s (CCCR) Colorectal Cancer Prevention Network (CCPN) at the 
University of South Carolina. The program provides free colonoscopy screenings to those 
who are uninsured in South Carolina. All CCPN patients included within this study were 
those whose colonoscopies took place between May 2014 and May 2017.  
To be eligible to participate in the CCPN program, participants must be between 
50-64 years old (45-64 for African Americans), live at or below 150% of the poverty line, 
be asymptomatic of colorectal cancer, and pursuing medical care at participating free 
medical clinics, federally qualified health centers, or hospital indigent practices in SC. 
All CCPN screenings are performed by board-certified gastroenterologists.28 Patients 
were excluded from the program if they had a previous colonoscopy within the past 10 
years, had recent onset of CRC symptoms, a diagnosis of inherited CRC disorder, or a 
history of gastrointestinal disease or a cancer other than a non-melanoma skin cancer.28 
Data on each individual’s demographic, personal and family medical history, and 
behavioral factors was collected through an in-person interview 5-10 days before their 
colonoscopy procedure. During this time, the participants were also instructed on the 
process of colonoscopy and the colonic preparation process. After the colonoscopy, 
endoscopy and pathology report data are then stored in the same database which captured 
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all other patient information. All data are collected and managed in a HIPAA-compliant, 
cloud-based system by the CCPN navigators and staff.28
3.2 OUTCOME ASSESSMENT 
 Our main outcome of interest was the number of polyps found during 
colonoscopy which was treated as any type of polyp removed from colonoscopy and 
assessed as a count variable. Biopsies with a pathology report indicating the removed 
lesion as a carcinoid/cancerous were excluded from the study since we’re assessing 
polyps that were removed in order to potentially prevent cancer. A lesion was considered 
a polyp if initially indicated by the physician at time of removal via the endoscopy report, 
rather than by pathologic examination outcome.  
We first assessed the polyp detection rate (PDR) defined as the percentage of 
patients that underwent colonoscopy who had at least one polyp removed. We then 
calculated the mean, median, and max number of polyps for all polyps removed overall 
and by type of polyp removed. Type of polyp was classified as either: “low-risk polyp” 
(hyperplastic polyps <1cm in diameter and non-advanced polyps <1cm in diameter), or 
“high-risk polyp” (advanced polyps ³1cm in diameter including hyperplastic, traditional 
serrated, sessile serrated, or any polyp with villous components and/ or high-grade 
dysplasia).28,31,33,34 Furthermore, polyps which had pathology reports indicating 
inflammation or normal colonic mucosa were classified as low-risk. Patients that did not 
have a pathology report or were missing pathology information on lesion classification 
were excluded. 
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3.3 INDEPENDENT VARIABLES 
 Our independent variables included gender (male or female), race 
(Caucasian/white, African-American/black, or other), age (45-49, 50-54, 55-59, and 60-
64 year olds), smokers (current, former, or non-smoker), alcohol consumption (heavy, 
moderate, or light/non-drinker), BMI (normal/underweight, overweight, or obese), 
residence location (rural/urban), family history of CRC (yes/no), highest educational 
level obtained (less than high school, high school diploma/GED, some college, or college 
degree). Family history of CRC was “yes” if at least one first-degree relative (mother, 
father, or sibling) had ever been diagnosed with CRC. Rural or urban status of residence 
location was categorized by the 2010 Rural-Urban Commuting Area (RUCA) U.S. 
census classification of the zip-code for which the participant resided at the time of 
enrollment in the CCPN program (in-person navigation appointment). Since the 45-49 
age group only consisted of African-Americans, our reference group for age was 60-64. 
All other reference groups for these independent variables were those which research has 
shown to be the least at-risk for developing polyps: females, Caucasians, non-smokers, 
light/non-drinkers, normal/underweight BMI, urban residents, no family history of CRC, 
and college degree. 
NSAID use was based on each participant’s response to the amount of 
NSAIDs/Aspirin they took per week over the four months previous to their procedure. 
We categorized NSAID use into either “Never” take NSAIDs if never take them, 
“Occasionally” if they reported taking them either <1/week or <1/month, “1-3 
days/week”, “4-6 days/week”, and “7 days/week”. Since taking NSAIDs is considered a 
protective factor for CRC, we used the “7 days/week” category as our reference group.  
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 Physical activity was assessed based on the number of days within the week prior 
to procedure which the participant engaged in vigorous physical activity for at least 10 
minutes. The numbers of days were categorized into “0 days/week”, “1-3 days/week”, or 
“4-7 days/week”. Since frequent exercisers are considered the most low-risk physical 
activity group, we used the “4-7 days/week” category as our reference group. 
In accordance to CDC guidelines, smoking status was categorized for cigarette, 
pipe, cigar, and smokeless tobacco use based on each individual’s current smoking status, 
whether they had smoked at least 100 units (of cigarettes, etc.) within their lifetime, and 
if they have smoked on a regular basis for more than a year.48 Non-smokers were 
classified as those which had smoked less than 100 units in their lifetime. Current 
smokers were those which reported that they currently smoke. Former smokers were 
individuals who did not report smoking currently, have smoked at least 100 units in their 
lifetime, and/or smoked regularly for at least a year. 
 Alcohol use was defined by the number of drinks an individual had per week for 
all alcohol types (beer, wine, malt liquor, hard liquor/mixed drinks/shots/cocktails). In 
accordance with NIAAA guidelines,49 alcohol use was categorized into either “heavy 
drinker,” “moderate drinker,” or “light/non-drinker” and took into account gender. For 
males: heavy drinkers consumed at least 14.5 drinks/week, moderate drinkers consumed 
>1 and <14.5 drinks/week, and light/non-drinkers consumed 1 or less drinks/week. For 
females: heavy drinkers consumed at least 7.5 drinks/week, moderate drinkers consumed 
>1 and <7.5 drinks/week, and light/non-drinkers consumed 1 or less drinks/week. 
 BMI measurements were expressed as kg/m2 and defined in accordance with the 
World Health Organization (WHO) guidelines where <18.5 is “Underweight,” 18.5- 
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24.99 “Normal,” 25-29.99 “Overweight,” and ³30.0 “Obese.”50 Normal and underweight 
BMI’s were combined into the category “Normal/underweight.” BMI was calculated by 
study investigators prior to our secondary analysis. 
Since bowel preparation has been shown to affect our outcome of interest, we also 
included this variable in our analysis. The performing physician rated each individual’s 
preparation quality as either (1) “excellent” (REX scale D, only scattered, tiny particles 
and/or clear liquid, 100% visualization possible throughout colon), (2) “good” (REX 
scale C, “adequate”, easily removable small amounts of particles and/or liquid, very 
unlikely to impair visualization), (3) “fair” (REX scale B, residual feces and/or non-
transparent fluid, possible impairing visualization), (4) “poor” (REX scale A, feces and/or 
non-transparent fluid, definitely impairing visualization), or (5) “other.” Bowel 
preparation quality was categorized into “Excellent/Good” for those which were rated 
excellent or good, and “Fair/Poor” for those which were considered fair or poor. 
Colonoscopies which were documented as “Other” or did not have bowel preparation 
quality documented were excluded from the study.  
Procedure time was based on procedure start time and categorized as: before 
10:00am, 10:00am-2:00pm, and after 2:00pm. Since previous studies have found the 
morning procedures to be the most successful at detecting polyps, the before 10:00am 
category served as our reference group. 
  
3.5 ANALYSIS 
 We first described the characteristics of our study participants for each of our 
independent variables. Since all of our variables are categorical, we described them as the 
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total number and percentage. Next, we calculated the PDR as the proportion of 
colonoscopies which resulted in the removal of one or more polyps. To test for 
differences in PDR between independent variable categories, we performed a chi-squared 
analysis. P-values were compared to α=0.05. We also described the number and 
percentage of colonoscopies which resulted in no polyps removed. Additionally, we 
described the mean, median, and max number of polyps overall and by risk type (low- 
and high-risk) for each independent variable.  
We performed a univariate negative binomial regression analysis to assess the 
relationship between total number of polyps detected and each independent variable by 
itself. We then performed a multivariable negative binomial regression to assess the 
association between the number of polyps detected and all of our independent variables 
together. We repeated these univariate and multivariable negative binomial regression 
analyses for number of high-risk polyps detected. For all regression analyses, we 
calculated the rate ratio (RR) and 95% confidence intervals (95% CI). Finally, we tested 
for interaction in both multivariable models among variables which research showed may 
interact (BMI and gender; BMI and race; physical activity and gender; physical activity 
and race; NSAIDs and age; NSAIDs and BMI; family history of CRC and gender; family 
history of CRC and age). We first assessed the significance of these interaction terms 
individually within the multivariable model that contained all independent variables. 
Interaction terms that had a significant individual p-value (α=0.05) were all initially 
added into the multivariable model together, and then the remaining significant 
interaction terms were included within our final model. All analyses were performed 
using SAS software version 9.4. The study was approved by the University of South 
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Carolina Institutional Review Board, and data usage approved by the CCSR Advisory 
Committee.  
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CHAPTER 4 
RESULTS 
4.1 SAMPLE CHARACTERISTICS 
 There were a total of 1,541 colonoscopies performed by the CCPN between May 
2014 and May 2017. We then excluded patients who did not give consent to participate in 
the research data registry, whose colonoscopy procedure report was still pending, had an 
incomplete/aborted colonoscopy, had only cancerous/carcinoid lesions removed, had no 
pathology reports or missing pathology information, and individuals missing information 
on our independent variables (n=551). Our final sample consisted of 990 individuals. 
Additional details on sample inclusion are demonstrated in Figure 4.1. The independent 
variable categories with the highest proportions in our sample, as described in Table 4.1, 
were individuals aged 50-54 (44.75%), African-Americans (52.73%), females (60.81%), 
current smokers (40.10%), urban area residents (84.75%), light/non-drinkers (68.38%), 
zero days/week exercisers (74.44%), had no family history of CRC (91.11%), high school 
diploma/GED (42.22%), excellent/good bowel preparation quality (90.61%), had a 
scheduled endoscopy procedure time between 10:00am and 2:00pm (40.01%), obese 
(50.30%), and never took NSAIDs in the four months prior to procedure (42.53%).  
 
4.2 POLYP DETECTION RATE 
The overall PDR was 61.82% (Table 4.1). Results from our chi-squared test of 
independence showed a significantly higher PDR in males than females (p=<.0001),
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urban residents than rural residents (p=0.0029), and those with a family history of CRC 
than those without (p=0.0481). The age group with the highest PDR were those aged 55-
59 years, and the lowest were those aged 50-54 (p=0.0444). For the smoking category, 
current smokers had the highest PDR and non-smokers had the lowest (p=<.0001). Heavy 
drinkers were the most likely to have a polyp detected while non/light drinkers were the 
least likely (p=0.0117). No significant differences in PDR were found between race, 
physical activity, education, bowel preparation quality, procedure time, BMI, or NSAID 
use.  
 
4.3 MEAN, MEDIAN, AND MAX OF NUMBER OF POLYPS 
 The total respective mean, median, and max of number of polyps removed were 
1.65, 1.00, and 15 for all polyps, 1.34, 1.00, and 13 for low-risk polyps, and 0.31, 0, and 
13 for high-risk polyps (Table 4.2). The category with the highest mean number of all 
polyps and high-risk polyps, respectively, removed for each independent variable were: 
“other” race, males, current smokers, urban residents, family history of CRC, less than a 
high school education, and having a procedure time before 10:00am. Those who were 55-
59 years old had the highest mean all polyps while 60-64 year old’s had the highest mean 
of high-risk. Individuals who exercised 4-7 days/week had the highest mean for all 
polyps and zero days/week had the highest mean for high-risk. Overweight individuals 
had the highest mean for all polyps, and normal/underweight individuals had the highest 
mean for high-risk polyps. Highest mean for all polyps for NSAID use was among those 
who never took them, and among 1-3 days/week users for high-risk polyps. Patients who 
had excellent/good bowel preparation quality had a higher mean number of high-risk 
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polyps removed, but the mean for fair/poor preparation was higher for all polyps. Both 
moderate and heavy drinkers had the highest mean number of high-risk polyps, but only 
heavy drinkers had the highest mean for all polyps. 
 
4.4 REGRESSION ANALYSIS FOR NUMBER OF ALL POLYPS  
For our multivariable model, we performed a negative binomial regression 
analysis instead of a Poisson regression analysis as the deviance test showed a better fit 
for our data. We found significant rate ratios for gender, smoking, rural/urban residence, 
alcohol use, family history of CRC, BMI, and NSAIDs. Since our multivariable model 
contained all independent variables, findings for each variable were adjusted for all other 
variables. The rate of polyps detected for males is 1.26 times the rate of polyps detected 
among females (95% CI 1.07-1.48). Current smokers (RR=2.04, 95% CI 1.70-2.44) and 
former smokers (RR=1.57, 95% CI 1.28-1.94) both had significantly higher rate ratios 
when compared to non-smokers. The rate of polyps detected among rural residents is 
0.62 times the rate of polyps among urban residents (95% CI 0.50-0.78). Moderate 
drinkers had a significantly higher rate ratio when compared to non/light drinkers 
(RR=1.22, 95% CI 1.02-1.46), but no difference was found between heavy and non/light 
drinkers. The rate of polyps among individuals with a family history of CRC was 1.34 
times the rate of polyps among individuals with no family history of CRC (95% CI 1.04-
1.74). When compared to normal/underweight individuals, obese individuals had a 
significantly higher rate ratio (RR=1.35, 95% CI 1.09-1.67), but no difference was 
detected between overweight and normal/underweight individuals. Lastly, the rate of 
polyps for those who never take NSAIDs was 1.40 times the rate of polyps for those who 
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take NSAIDs 7 days/week (95% CI 1.15-1.71). No significant associations were found 
between number of polyps and age, education, bowel preparation, or procedure time. 
When testing for interaction within the multivariable analysis, we found a 
significant interaction between physical activity and race. In terms of race: among 
individuals who exercised 4-7 days/week, African-Americans had a mean number of 
polyps about 49% lower than whites (RR=0.51, 95% CI 0.33-0.79) (Table 4.4). In terms 
of physical activity: among African-Americans, individuals who exercised zero 
days/week had a mean number of polyps about 49% higher than individuals who 
exercised 4-7 days/week (RR=1.49, 95% CI 1.04-2.11) (Table 4.5). No evidence of 
interaction was found among any other variables.  
 
4.5 REGRESSION ANALYSIS FOR NUMBER OF HIGH-RISK POLYPS 
 We also performed a negative binomial regression analysis for high-risk polyp 
number since it better predicted the probability of detecting the large amount of zero 
high-risk polyps in our model than Poisson regression. Since no high-risk polyps were 
detected for individuals aged 45-49, we excluded this age group from our regression 
analysis assessing number of high-risk polyps (n=45). Therefore, our total sample size for 
this analysis was n=945. We found significant associations between number of high-risk 
polyps with gender, smoking, procedure time, and NSAIDs. Since our multivariable 
model contained all independent variables, findings for each variable were adjusted for 
all other variables. The rate of polyps removed for males were 1.82 times the rate of 
polyps removed for females (95% CI 1.15-2.89). The rate of polyps removed for current 
smokers is 2.53 times the rate for number of polyps removed among non-smokers (95% 
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CI 1.48-4.32). No difference was detected when comparing former smokers to non-
smokers. The rate of polyps removed for procedure times that occurred after 2:00pm was 
0.52 times the rate of polyps removed for procedures which took place before 10:00am 
(95% CI 0.29-0.94). Lastly, significant associations were found when individuals who 
took NSAIDs every day were compared to individuals who took them 1-3 days/week 
(RR=2.93, 95% CI 1.40-6.12), occasionally (RR=2.02, 95% CI 1.01-4.05), and never 
took them (RR=1.86, 95% CI 1.04-3.34). No significant associations were found between 
number of high-risk polyps and age, race, rural/urban location, alcohol, physical activity, 
family history of CRC, education, bowel preparation, or BMI. Additionally, no 
significant interaction between independent variables was found. 
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Figure 4.1: Flow Diagram of Sample Inclusion 
 
 
 
 
 
 
 
Total patients who received a 
colonoscopy between May 
2014 and May 2017 
(n=1541) 
Excluded, in sequential order 
(n=551) 
• No consent given for 
participation in Research Data 
Registry (n=401) 
• Colonoscopy procedure report 
still pending (n=2)  
• Incomplete/Aborted 
colonoscopies (n=9) 
• Patients who had only lesions 
removed which qualified as 
cancerous (n=4) 
• Patients with no pathology 
reports/missing pathology 
information (n=81) 
• Missing independent variable 
information (n=54) 
	
Final analytic sample 
(n=990) 
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Table 4.1: PDR by Sample Characteristics, May 2014-May 2017 
 
 
Characteristics 
 No Polyps 
Removed 
³ 1 Polyp 
Removed (PDR) 
 
P-valuea 
 N% n (%) n (%)  
Total 990 378 (38.18) 612 (61.82)  
Ageb    0.0444 
45-49 45 (4.55)c 19 (42.22) 26 (57.78)  
50-54 443 (44.75) 189 (42.66) 254 (57.34)  
55-59 307 (31.01) 103 (33.55) 204 (66.45)  
60-64 195 (19.70) 67 (34.36) 128 (65.64)  
Race    0.2505 
Caucasian 443 (44.75) 157 (35.44) 286 (64.56)  
African-American 522 (52.73) 212 (40.61) 310 (59.39)  
Other 25 (2.53) 9 (36.00) 16 (64.00)  
Gender    <.0001 
Female 602 (60.81) 259 (43.02) 343 (56.98)  
Male  388 (39.19) 119 (30.67) 269 (69.33)  
Smoking Status    <.0001 
Non-Smoker 389 (39.29) 192 (49.36) 197 (50.64)  
Former 204 (20.61) 76 (37.25) 128 (62.75)  
Current 397 (40.10) 110 (27.71) 287 (72.29)  
Location    0.0029 
Urban 839 (84.75) 304 (36.23) 535 (63.77)  
Rural 151 (15.25) 74 (49.01) 77 (50.99)  
Alcohol Use    0.0117 
Non-Drinker/Light 677 (68.38) 278 (41.06) 399 (58.94)  
Moderate 264 (26.67) 88 (33.33) 176 (66.67)  
Heavy 49 (4.95) 12 (24.49) 37 (75.51)  
Physical Activity    0.5514 
4-7 days/week 110 (11.11) 38 (34.55) 72 (65.45)  
1-3 days/week  143 (14.44) 59 (41.26) 84 (58.74)  
0 days/week 737 (74.44) 281 (38.13) 456 (61.87)  
Family History     0.0481 
No 902 (91.11) 353 (39.14) 549 (60.86)  
Yes 88 (8.89) 25 (28.41) 63 (71.59)  
Education     0.3417 
College Degree 136 (13.74) 57 (41.91) 79 (58.09)  
Some College  186 (18.79) 72 (38.71) 114 (61.29)  
HS Diploma/GED 418 (42.22) 165 (39.47) 253 (60.53)  
Less than HS  250 (25.25) 84 (33.60) 166 (66.40)  
Bowel Preparation     0.4338 
Excellent/Good 897 (90.61) 339 (37.79) 558 (62.21)  
Fair/Poor 93 (9.39) 39 (41.94) 54 (58.06)  
Procedure Time    0.7472 
Before 10:00am 244 (24.65) 98 (40.16) 146 (59.84)  
10:00am-2:00pm 406 (41.01) 151 (37.19) 255 (62.81)  
After 2:00pm 340 (34.34) 129 (37.94) 211 (62.06)  
BMI    0.3299 
Normal/Underweight 190 (19.19) 66 (34.74) 124 (65.26)  
Overweight 302 (30.51) 111 (36.75) 191 (63.25)  
Obese 498 (50.30) 201 (40.36) 297 (59.64)  
NSAID Use    0.1115 
Every Day 213 (21.52) 85 (39.91) 128 (60.09)  
4-6 days/ week 43 (4.34) 13 (30.23) 30 (69.77)  
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1-3 days/week 137 (13.84) 49 (35.77) 88 (64.23)  
Occasionally 176 (17.78) 81 (46.02) 95 (53.98)  
Never 421 (42.53) 150 (35.63) 271 (64.37)  
aP-values were calculated from a chi-square test and compare each patient characteristic (rows) to 
the outcomes (columns); bAge at inclusion; age group 45-49 includes African-American 
participants only; call percentages rounded to two decimal points which may impact total 
percentage equaling 100% 
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Table 4.2: Mean, Median, and Max of Polyp Count Overall and by Type 
 
Characteristics 
All  
Polyps  
Low-Risk  
Polypsa 
High-Risk  
Polyps 
 Meanb, Median (Max) Mean, Median (Max) Mean, Median (Max) 
Total 1.65, 1.00 (15) 1.34, 1.00 (13) 0.31, 0 (13) 
Agec    
45-49 1.29, 1.00 (8) 1.29, 1.00 (8) 0, 0 (0)d 
50-54 1.54, 1.00 (15) 1.23, 0 (12) 0.31, 0 (13) 
55-59 1.81, 1.00 (13) 1.49, 1.00 (13) 0.33, 0 (7) 
60-64 1.72, 1.00 (11) 1.35, 1.00 (10) 0.36, 0 (8) 
Race    
Caucasian 1.74, 1.00 (15) 1.39, 1.00 (13) 0.35, 0 (13) 
African-American 1.55, 1.00 (13) 1.29, 1.00 (12) 0.27, 0 (13) 
Other 2.00, 1.00 (12) 1.40, 1.00 (9) 0.60, 0 (5) 
Gender    
Female 1.44, 1.00 (12) 1.23, 1.00 (12) 0.22, 0 (8) 
Male  1.97, 1.00 (15) 1.51, 1.00 (13) 0.46, 0 (13) 
Smoking Status    
Non-Smoker 1.08, 1.00 (12) 0.92, 0 (10) 0.16, 0 (6) 
Former 1.75, 1.00 (13) 1.46, 1.00 (13) 0.30, 0 (7) 
Current 2.15, 2.00 (15) 1.68, 1.00 (11) 0.47, 0 (13) 
Location    
Urban 1.73, 1.00 (15) 1.41, 1.00 (13) 0.32, 0 (13) 
Rural 1.20, 1.00 (10) 0.93, 0 (8) 0.27, 0 (4) 
Alcohol Use    
Non-Drinker/Light 1.51, 1.00 (13) 1.24, 1.00 (13) 0.27, 0 (8) 
Moderate 1.95, 1.00 (15) 1.55, 1.00 (11) 0.41, 0 (13) 
Heavy 1.96, 2.00 (9) 1.55, 1.00 (9) 0.41, 0 (4) 
Physical Activity    
4-7 days/week 1.93, 1.00 (13) 1.65, 1.00 (13) 0.28, 0 (4) 
1-3 days/week  1.37, 1.00 (12) 1.16, 0 (12) 0.21, 0 (4) 
0 days/week 1.66, 1.00 (15) 1.32, 1.00 (11) 0.34, 0 (13) 
Family History     
No 1.61, 1.00 (15) 1.30, 1.00 (13) 0.30, 0 (13) 
Yes 2.07, 1.00 (10) 1.67, 1.00 (8) 0.40, 0 (6) 
Education     
College Degree 1.50, 1.00 (13) 1.31, 0 (13) 0.19, 0 (2) 
Some College  1.58, 1.00 (12) 1.29, 1.00 (12) 0.29, 0 (8) 
HS Diploma/GED 1.61, 1.00 (13) 1.35, 1.00 (9) 0.26, 0 (13) 
Less than HS  1.84, 1.00 (15) 1.36, 1.00 (11) 0.48, 0 (13) 
Bowel Preparation     
Excellent/Good 1.64, 1.00 (15) 1.32, 1.00 (13) 0.32, 0 (13) 
Fair/Poor 1.72, 1.00 (11) 1.45, 1.00 (10) 0.27, 0 (6) 
Procedure Time    
Before 10:00am 1.72, 1.00 (15) 1.32, 1.00 (9) 0.40, 0 (13) 
10:00am-2:00pm 1.67, 1.00 (12) 1.34, 1.00 (12) 0.33, 0 (8) 
After 2:00pm 1.57, 1.00 (13) 1.34, 1.00 (13) 0.23, 0 (7) 
BMI    
Normal/Underweight 1.66, 1.00 (13) 1.28, 1.00 (13) 0.38, 0 (13) 
Overweight 1.70, 1.00 (10) 1.37, 1.00 (9) 0.33, 0 (8) 
Obese 1.61, 1.00 (15) 1.34, 1.00 (12) 0.28, 0 (13) 
NSAID Use    
Every Day 1.38, 1.00 (11) 1.19, 1.00 (9) 0.19, 0 (6) 
4-6 days/ week 1.65, 1.00 (9) 1.35, 1.00 (6) 0.30, 0 (6) 
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1-3 days/week 1.74, 1.00 (10) 1.34, 1.00 (10) 0.39, 0 (6) 
Occasionally 1.40, 1.00 (13) 1.10, 0 (13) 0.30, 0 (6) 
Never 1.86, 1.00 (15) 1.50, 1.00 (12) 0.36, 0 (13) 
aLow-risk polyp group contains polyps classified as inflammation or normal colonic mucosa; bSome 
low-risk and high-risk polyp means do not sum to their respective all polyp mean due to rounding; 
cAge at inclusion; age group 45-49 includes African-American participants only; dNo high-risk 
polyps were found among those aged 45-49 
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Table 4.3: Negative Binomial Regression for Number of Polyps (Overall & High-Risk) 
 All Polyps (n=990) High-Risk Polyps (n=945)b 
 Univariate Multivariablea Univariate Multivariable 
Characteristic RR 95% CI RR 95% CI RR 95% CI RR 95% CI 
Age         
45-49 0.75 (0.49, 1.14) 0.84 (0.56, 1.27) NA NA NA NA 
50-54 0.90 (0.73, 1.11) 0.88 (0.72, 1.07) 0.86 (0.50, 1.48) 0.62 (0.36, 1.07) 
55-59 1.05 (0.84, 1.32) 1.04 (0.84, 1.28) 0.89 (0.50, 1.60) 0.71 (0.40, 1.24) 
60-64 REF NA REF NA REF NA REF NA 
Race         
Caucasian REF NA NAc NA REF NA REF NA 
African-American 0.89 (0.76, 1.05) NA NA 0.84 (0.55, 1.28) 0.72 (0.46, 1.12) 
Other 1.15 (0.71, 1.87) NA NA 1.71 (0.50, 5.82) 2.64 (0.79, 8.79) 
Gender         
Female REF NA REF NA REF NA REF NA 
Male  1.36 (1.16, 1.59) 1.26 (1.07, 1.48) 2.13 (1.41, 3.22) 1.82 (1.15, 2.89) 
Smoking Status         
Non-Smoker REF NA REF NA REF NA REF NA 
Former 1.62 (1.31, 2.00) 1.57 (1.28, 1.94) 1.79 (1.01, 3.18) 1.60 (0.88, 2.91) 
Current 1.99 (1.67, 2.36) 2.04 (1.70, 2.44) 2.78 (1.74, 4.44) 2.53 (1.48, 4.32) 
Location         
Urban REF NA REF NA REF NA REF NA 
Rural 0.69 (0.55, 0.87) 0.62 (0.50, 0.78) 0.81 (0.45, 1.46) 0.68 (0.36, 1.25) 
Alcohol Use         
Non-Drinker/Light REF NA REF NA REF NA REF NA 
Moderate 1.29 (1.09, 1.54) 1.22 (1.02, 1.46) 1.52 (0.96, 2.41) 1.24 (0.73, 2.11) 
Heavy 1.30 (0.91, 1.85) 1.17 (0.83, 1.64) 1.58 (0.62, 4.05) 1.23 (0.48, 3.20) 
Physical Activity         
4-7 days/week REF NA NAc NA REF NA REF NA 
1-3 days/week  0.71 (0.52, 0.97) NA NA 0.76 (0.32, 1.79) 0.85 (0.36, 2.03) 
0 days/week 0.86 (0.67, 1.10) NA NA 1.19 (0.61, 2.34) 1.79 (0.88, 3.66) 
Family History          
No REF NA REF NA REF NA REF NA 
Yes 1.29 (0.99, 1.68) 1.34 (1.04, 1.74) 1.29 (0.64, 2.61) 1.33 (0.64, 2.77) 
Education          
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College Degree REF NA REF NA REF NA REF NA 
Some College  1.05 (0.80, 1.40) 0.85 (0.65, 1.12) 1.49 (0.70, 3.20) 1.18 (0.54, 2.57) 
HS Diploma/GED 1.07 (0.84, 1.37) 0.90 (0.71, 1.15) 1.42 (0.72, 2.81) 1.16 (0.58, 2.32) 
Less than HS  1.23 (0.95, 1.60) 0.95 (0.74, 1.24) 2.50 (1.23, 5.08) 1.77 (0.84, 3.71) 
Bowel Preparation          
Excellent/Good REF NA REF NA REF NA REF NA 
Fair/Poor 1.05 (0.80, 1.37) 1.05 (0.82, 1.36) 0.82 (0.40, 1.69) 1.01 (0.49, 2.10) 
Procedure Time         
Before 10:00am REF NA REF NA REF NA REF NA 
10:00am-2:00pm 0.97 (0.80, 1.19) 0.98 (0.81, 1.19) 0.83 (0.50, 1.38) 0.88 (0.52, 1.49) 
After 2:00pm 0.91 (0.74, 1.12) 0.88 (0.72, 1.09) 0.59 (0.34, 1.02) 0.52 (0.29, 0.94) 
BMI         
Normal/Underweight REF NA REF NA REF NA REF NA 
Overweight 1.02 (0.82, 1.29) 1.24 (1.00, 1.56) 0.90 (0.50, 1.62) 1.34 (0.71, 2.52) 
Obese 0.97 (0.79, 1.20) 1.35 (1.09, 1.67) 0.75 (0.43, 1.29) 1.30 (0.70, 2.43) 
NSAID Use         
Every Day REF NA REF NA REF NA REF NA 
4-6 days/ week 1.19 (0.79, 1.80) 1.21 (0.82, 1.79) 1.54 (0.52, 4.60) 1.24 (0.40, 3.85) 
1-3 days/week 1.25 (0.96, 1.64) 1.28 (0.99, 1.66) 2.07 (1.01, 4.25) 2.93 (1.40, 6.12) 
Occasionally 1.01 (0.78, 1.31) 1.07 (0.84, 1.38) 1.54 (0.77, 3.06) 2.02 (1.01, 4.05) 
Never 1.34 (1.09, 1.65) 1.40 (1.15, 1.71) 1.86 (1.05, 3.30) 1.86 (1.04, 3.34) 
aMultivariable analysis for all polyps includes all independent variables and an interaction term for race and physical activity; bIndividuals aged 
45-49 were removed from our number of high-risk polyps analyses (n=45) due to no high-risk polyps being detected among this group- all 
independent variables included in analysis; cSince race and physical activity had significant interaction, the rate ratios for these variables are 
reported in subsequent tables 
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Table 4.4: Rate Ratios for Number of All Polyps for Race by Physical Activity  
 Race 
 African-American Other White 
Physical Activity  RRa 95% CI RR 95% CI RR 95% CI 
0 days/week 1.02 (0.85, 1.22) 1.63 (0.94, 2.83) REF NA 
1-3 days/week 0.92 (0.60, 1.40) 0.31 (0.06, 1.63) REF NA 
4-7 days/week 0.51 (0.33, 0.79) 1.35 (0.46, 3.94) REF NA 
aRate ratios in these analyses compare the mean number of polyps removed 
 
Table 4.5: Rate Ratios for Number of All Polyps for Physical Activity by Race 
 Physical Activity 
 0 days/week 1-3 days/week 4-7 days/week 
Race RRa 95% CI RR 95% CI RR 95% CI 
African-American 1.49 (1.04, 2.11) 1.19 (0.78, 1.81) REF NA 
Other 0.90 (0.28, 2.88) 0.15 (0.02, 1.03) REF NA 
White 0.74 (0.53, 1.04) 0.66 (0.42, 1.02) REF NA 
aRate ratios in these analyses compare the mean number of polyps removed 
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CHAPTER 5 
DISCUSSION 
5.1 KEY FINDINGS 
 The overall PDR found within this study (61.82%) is comparable to that found in 
the earlier CCPN study of May 2014-May 2016 patients (62.71%).28 A previous study 
found a 37% PDR among uninsured individuals in New York.51 To compare these 
numbers to insured individuals, the PDR in a national study among Medicare 
beneficiaries varied between 23.9% and 35.7% depending on the specificity of polyp 
definition.52 Our higher PDR findings are likely due to 90.61% of our sample having 
good-to-excellent bowel preparation, having all procedures performed by board-certified 
gastroenterologists, and the distribution of individual characteristics in our SC sample. 
Our chi-squared analysis found significant differences in PDR among age, gender, 
smoking status, rural/urban residence, alcohol use, and family history of CRC.  
Our multivariable negative binomial regression model showed significant 
associations between number of all polyps and gender, smoking, rural/urban residence, 
alcohol, family history of CRC, BMI, and NSAIDs. Additionally, significant interaction 
was found between race and physical activity. Our multivariable negative binomial model 
for high-risk polyps only found significant associations for gender, smoking, procedure 
time, and NSAIDs. No other significant associations were found in either model. 
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Age 
Since previous literature has demonstrated that the risk for polyps increases with 
age,1,2,19,24,35 we expected our PDR, and number of polyps to be highest among the 60-64 
age group. Although the highest mean number of high-risk polyps was amongst this age 
group, the remaining results were highest among the 55-59 age group. However, the 60-
64 age group still had higher results when compared to the two younger age groups. All 
regression models found age to be non-significant.  
 
Race  
Our results for race were not as expected since previous literature has found 
African-Americans more at risk for colonic polyps compared to all other races.1,2,18,22 Our 
mean number of polyps found for all types were highest for other races and lowest for 
African-Americans. Furthermore, race was only significant in our all polyps model 
among individuals that exercised 4-7 days/week (RR=0.51, 95% CI 0.33-0.79), 
suggesting that African-Americans who exercise 4-7 days/week have a protective effect 
to number of polyps when compared to whites who exercise 4-7 days/week. Despite 
African-Americans being a high-risk group for colonic polyp development, this finding is 
only among those who frequently exercise; therefore, these individuals are likely of better 
health than other African-Americans who do not exercise as frequently. These findings 
further emphasize the results in a previous study which found African-Americans to be 
one of the racial/ethnic groups that benefit most from frequent exercise.22 Further- race 
was insignificant elsewhere in our models which aligns with findings in the previous 
CCPN study.28  Since our sample consisted of uninsured and poor individuals, race may 
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not be as significant within our study since socioeconomic status could be a proxy 
between race and polyp detection. 
 
Gender 
 Previous literature has found the risk of polyps, and specifically high-risk polyps, 
to be higher among males than females.18,19,26,35,36 Therefore, our results for gender were 
as expected as we also found males to have a significantly higher PDR, and a higher 
mean and max number of polyps. Both of our multivariable regression models also agree 
with previous findings as males were found to have a higher rate of polyps removed than 
females in our model of all polyps removed (RR=1.26, 95% CI 1.07-1.48) and in our 
model for high-risk polyps (RR=1.82, 95% CI 1.15-2.89). 
 
Smoking 
 Our results for smoking status also reinforce findings from previous 
studies.18,19,24,26,28,35,36 Current smokers had the largest PDR while non-smokers had the 
smallest PDR. This trend is further demonstrated by the mean number of overall, low-
risk, and high-risk polyps found. Our regression models found that compared to non-
smokers, both current (RR=2.04, 95% CI 1.70-2.44) and former smokers (RR=1.57, 95% 
CI 1.28-1.94) had a higher rate of overall polyps removed. For high-risk polyps, current 
smokers (RR=2.53, 95% CI 1.48-4.32) had higher rates of high-risk polyps removed 
when compared to non-smokers. 
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Urban/Rural Residence  
Our findings for urban/rural residents were not expected based on previous 
literature that has shown rural residents more at risk for the development of CRC than 
urban residents.43 However, a previous study on May 2014-May 2016 CCPN patients 
also found a higher PDR among urban residents compared to rural residents.28 In 
addition, our multivariable model for number of all polyps removed found living in a 
rural area to be protective against number of polyps (RR= 0.62, 95% CI 0.50-0.78). 
These unexpected results may be due to the difference in quality of performance for the 
physician. However, we were unable to acquire this data in order to test any random 
effect from the performing physician. These results may also be due to most CCPN 
recruiting facilities being within urban areas, so the rural patients in our sample are those 
who were seeking healthcare which could potentially mean they have better health 
behaviors.  
 
Alcohol Use 
 Previous studies have shown conflicting results on the relationship between 
alcohol use and polyp detection.2,27,35,36,40 Our results found that heavy drinkers had the 
highest PDR while non-drinkers had the lowest PDR. This was also the case for mean 
number of overall polyps, low-risk polyps, and high-risk polyps. Our multivariable 
regression models found only moderate drinkers to be significantly associated with 
number of all polyps removed (RR=1.22, 95% CI 1.02-1.46) when compared to non-
drinkers. No significant associations were found for heavy drinkers in either analysis, or 
for any category of alcohol use with high-risk polyps. 
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Physical Activity  
Our findings for physical activity were unexpected since previous literature has 
shown frequent physical activity as a protective factor against colonic polyps.22,28,36,38,39 
In our study, individuals who reported exercising at least 4 days/week had the highest 
mean number of all polyps and low-risk polyps. These unexpected results could be 
explained by the fact that physical activity was assessed as how many days of vigorous 
activity the patient engaged in within the week prior to colonoscopy. Therefore, physical 
activity levels may not accurately reflect each patient’s regular exercise habits. 
Additionally, there could be an inaccuracy within participant responses since they may 
not consider occupational or leisure activities that qualify as vigorous activity as such.  
Within our multivariable analysis for number of all polyps, physical activity was 
found only significant among African-Americans who exercised zero days/week 
compared to African-Americans who exercised 4-7 days/week (RR=1.49, 95% CI 1.04-
2.11). These findings support previous literature that African-Americans benefit more 
from the protective effects of physical activity on the detection of polyps than do 
whites.22  
 
Family History of CRC 
 Family history of CRC has been strongly associated with an increased risk of 
CRC and colonic polyps.2,23,38 Our results further reflect these findings as we found a 
significantly higher PDR for those with family history of CRC than those who did not 
have it. Additionally, our multivariable regression model found individuals with a family 
history of CRC to have a higher rate of all polyps removed (RR=1.34, 95% CI 1.04-1.74) 
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when compared to those with no family history of CRC. Family history was not 
significant in predicting number of high-risk polyps. 
 
Education 
 We were unable to find any significant differences in PDR between education 
levels as previous studies have suggested.26,35,36,41 Although, our univariate analysis 
found that those with less than a high school education had a higher rate of high-risk 
polyps detected than those who had a college degree (RR=2.50, 95% CI 1.23-5.08). 
However, when adjusting for all other independent variables, our multivariable regression 
model found education non-significant in predicting number of high-risk polyps. 
Education was not significant for either analysis assessing number of all polyps. 
 
Bowel Preparation Quality  
Our mean number of all polyps and low-risk polyps were the highest among those 
with fair/poor bowel preparation quality. These results were not expected since good-to-
excellent quality provides more clarity during the procedure and therefore usually results 
in more polyps removed.45,47 Because of this, we expected individuals with fair-to-poor 
bowel preparation to have a lower mean of polyps detected, and to find a significantly 
lower PDR. Bowel preparation was not found to be associated with number of all polyps 
removed or number of high-risk polyps removed. One possible explanation for this result 
could be that individuals in our sample who do not prepare their bowels to the good-to-
excellent quality may also have poor health behaviors that could potentially cause more 
polyps.  
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Procedure Time  
Our mean and max findings for procedure time were reflective of previous studies 
as morning procedure times have been found more likely to result in a polyp detected.46 
Procedure time after 2:00pm was found to result in a lower rate of high-risk polyps when 
compared to procedures before 10:00pm (RR=0.52, 95% CI 0.29-0.94) in our 
multivariable model. These results are likely due to morning procedures taking place at 
the beginning of the physician’s shift when they are more alert. However, we would 
expect procedure time to also be significant in our number of all polyps removed model 
since high-risk polyps are generally larger33,34 and may be easier to detect than low-risk 
polyps. Since we do not have information on the hours each physician worked during 
each colonoscopy they performed for our population, we were unable to assess this effect 
further. 
 
BMI  
Since previous literature has demonstrated that those who are overweight or obese 
are more at risk for colorectal polyps and advanced adenomas,2,18,19,24,26,36,37 our mean 
number of high-risk polyps for BMI were unexpected since the highest mean was 
amongst the underweight/normal group. However, our multivariable regression model for 
all polyps showed that the rate ratio was significant for obese when compared to 
normal/underweight (RR=1.35, 95% CI 1.09-1.67) but was not significant for overweight 
individuals. Additionally, no significant associations were found between BMI and 
number of high-risk polyps or in either univariate analysis. 
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NSAIDS  
The largest mean number of high-risk polyps among 1-3 day/week users was 
surprising since NSAIDs have been found to be preventive of high-risk polyps.2,26,36,42 
However, our regression analyses agreed with previous findings as those who never took 
NSAIDs had a higher rate of all polyps (RR=1.40, 95% CI 1.15-1.71) and number of 
high-risk polyps (RR=1.86, 95% CI 1.04-3.34). Our model for number of high-risk 
polyps also showed a higher rate among occasional NSAID users (RR=2.02, 95% CI 
1.01-4.05) and 1-3 days/week users (RR=2.93, 95% CI 1.40-6.12) when compared to 
individuals who take NSAIDs 7 days/week. The higher rate ratio for 1-3 day/week users 
than that of never users was also unexpected. Nonetheless, these findings confirm that 
more frequent use of NSAIDs is a protective factor against number of all polyps and 
high-risk polyps.  
 
5.2 LIMITATIONS AND STRENGTHS 
 One limitation to our study was that our sample consisted of only uninsured 
individuals; therefore, our results may not be generalizable to those who do have health 
insurance. Further, selection bias may be present since CCPN participants were referred 
to the program if they regularly received care from one of the participating federally-
qualified health centers or free medical clinics; therefore, all participants are individuals 
who are seeking out healthcare. Recall bias may also be a concern since many of our 
independent variables (alcohol use, NSAID use, physical activity, and smoking) relied on 
patient self-reported information. Lastly, our lack of ability to test for random physician 
effect to explain the unexpected findings for urban/rural residence was also a limitation. 
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A strength of our study was that 90% of our included participants had good-to-excellent 
bowel preparation quality, and all procedures were performed by board-certified 
gastroenterologists that perform a high volume of colonoscopy procedures; thus, making 
ideal conditions for precise colonoscopy readings. Despite these limitations, we consider 
our results to be accurate and to add important findings to the literature gap. 
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CHAPTER 6 
CONCLUSION 
 In conclusion, our results aligned with previous similar studies as our analyses 
showed that 55-59 year old individuals, males, current smokers, heavy drinkers, and 
individuals with a family history of CRC had a higher PDR that their counterparts. 
Differing from previous studies, our study found urban residents to be more likely to 
have a polyp detected than rural residents. We found gender, smoking habits, residence 
location (rural/urban), alcohol consumption, family history of CRC, BMI and NSAID use 
to be predictors of number of polyps removed during colonoscopy. Race was found 
significantly associated with number of all polyps only among individuals who exercised 
4-7 days/week; and physical activity was also significant for only African-Americans 
who exercised zero days/week. Number of high-risk polyps removed was found to be 
significantly associated with gender, smoking, time of procedure, and NSAID use. Since 
no other studies, to our knowledge, have assessed the effects of all of these factors on 
number of polyps, we are unable to compare our findings with similar study findings.  
 Future studies are needed to further assess what may be influencing the higher 
rate of polyps detected among urban residents found here, in addition to focusing on 
populations which include insured individuals since our results here are not generalizable 
to that population. Overall, our study demonstrates the effects that demographic, 
behavioral, and procedural influencers have on polyp detection and the number of polyps
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detected during a colonoscopy procedure. By assessing this relationship, our findings 
may help to identify individuals who are at risk for a large quantity of polyps which could 
perhaps improve the detection of more polyps during their colonoscopy procedure. 
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